Category: Science Explained
The word adaptogen is on every supplement shelf, but it means something specific. Here is the pharmacological definition, the three criteria a plant has to meet, which herbs genuinely qualify, and why no regulator officially recognises the term.
Category: Science Decoded | Reading time: ~9 min | Level: Intermediate
Walk down any supplement aisle and the word is everywhere. It sits on ashwagandha capsules, on mushroom powders, on functional sodas and on greens blends that cost more than a decent meal. Adaptogen has become a shorthand for something calming, natural and vaguely powerful, which is precisely the problem. A word doing that much marketing work usually stops meaning anything.
It does mean something specific, though, and the specific meaning is more interesting than the label suggests. The concept came out of Soviet pharmacology in the mid-twentieth century, was defined against real criteria, and applies honestly to a short list of plants. Most of the products carrying the word are not on that list. So this is a plain account of what an adaptogen actually is, the three tests a plant has to pass to earn the term, which herbs genuinely qualify, and the caveat that matters most: no regulator recognises the word at all.
An adaptogen is a plant compound proposed to help the body resist and recover from stress by nudging the stress response back toward balance, rather than pushing it up like a stimulant or down like a sedative. The idea is that the same herb can calm an overactive stress response and support a depleted one, a bidirectional or normalising effect, and that it does so across many different kinds of stressor rather than one specific target [1].
Mechanistically, the leading explanation is that adaptogens act on the systems that govern stress physiology, chiefly the HPA axis, the hormonal chain that controls cortisol, along with cellular stress-response pathways [1]. In the best-studied case, ashwagandha, this shows up as a reduction in elevated cortisol in chronically stressed people [2][4]. That is the core claim in one sentence: an adaptogen is meant to help you adapt to stress by regulating the response, not by masking it.
The term was coined by the Soviet pharmacologist Nikolai Lazarev in 1947 and developed by Israel Brekhman and colleagues over the following decades. Their framework, later refined by Alexander Panossian and colleagues, set out three conditions a substance has to meet to count as an adaptogen [1].
One: it reduces stress-induced damage. An adaptogen should measurably lower the harm a stressor causes, increasing what the original researchers called non-specific resistance. In practice this is the anti-stress claim: less physiological strain under load.
Two: it acts non-specifically. The effect should not be tied to a single stressor or a single organ. A true adaptogen raises resistance to a broad range of challenges, physical, chemical and psychological, rather than treating one named condition. This is what separates the concept from an ordinary drug with one target.
Three: it is innocuous. The substance should have a normalising influence and not disturb normal body function beyond what is needed to correct it. In plain terms, it should not throw the system out of balance in the other direction, and it should carry a low burden of harm at sensible doses.
Those three tests are demanding, and they are the reason the honest list of adaptogens is short. Meeting all three in properly designed human studies is a high bar, and most plants marketed with the word have never been tested against it.
Judged against the criteria and against human evidence rather than tradition alone, a small group stands out.
*Ashwagandha (Withania somnifera)* is the best-evidenced adaptogen by some distance. Multiple randomised trials in chronically stressed adults show reductions in cortisol and self-reported stress over roughly 60 days, with one widely cited study reporting a 27.9 per cent fall in serum cortisol [4]. The government evidence synthesis describes the stress evidence as promising rather than settled [2], which is the correct grade: moderate, and specific to stressed populations.
*Rhodiola (Rhodiola rosea)* holds a European traditional-use registration for temporary stress-related fatigue and weakness [3]. Its human evidence for fatigue is moderate at best and the trial quality is mixed, but it fits the adaptogen concept better than most.
*Asian ginseng (Panax ginseng)* has a long research history and some support for fatigue and mental performance, though results are inconsistent and effect sizes modest.
Beyond that shortlist, the evidence drops off sharply. A large tail of mushrooms, roots and berries is sold as adaptogenic on the strength of traditional use and laboratory studies, with little or no human trial data for stress-related outcomes. That does not make them worthless, but it does mean the adaptogen label is describing a hope, not a demonstrated effect.
Here is the part the marketing never mentions. Adaptogen is a functional and pharmacological term, not a regulatory one. No medicines regulator recognises it. The MHRA in the UK, the European Medicines Agency and the US FDA have no adaptogen category, no adaptogen standard and no approval process attached to the word.
This has a concrete consequence. When a product calls itself an adaptogen, or an adaptogenic blend, it has cleared no official bar by using that word. The term is not policing dose, quality, evidence or even which plant is inside. A capsule of well-studied, standardised ashwagandha and a scoop of an untested mushroom blend can both wear the label with equal legitimacy, because the label is not defined by anyone with authority to define it.
So the useful move is to ignore the word and look through it. Which specific herb is this? At what dose? Has that herb, at that dose, been studied in people? For ashwagandha the answers are reassuringly concrete. For much of what is sold as adaptogenic, the answers evaporate on contact.
If you are drawn to the idea of a plant that helps you handle stress, the concept is real and, for a couple of herbs, reasonably supported. The way to use it well is to treat adaptogen as a starting question, not a finishing answer.
Start with the best-evidenced option rather than the trendiest. For most people that means ashwagandha, understood on honest terms: moderate evidence, a benefit concentrated in people who are genuinely stressed, and a timescale of about two months rather than overnight [2][4]. Set that expectation before you start, because the slow, regulatory action is the whole point of the category and also the thing most likely to disappoint someone expecting an instant effect.
Judge the product by the herb and the dose, not the word on the front. A named single herb, standardised, at a dose used in trials, tells you far more than a proprietary adaptogen complex. And remember that innocuous is a claim about the category, not a promise for every plant: individual adaptogens carry real cautions, which is where safety comes in.
Low harm at sensible doses is one of the founding criteria, but it applies unevenly across the herbs sold under the label, and it is not the same as safe for everyone.
Ashwagandha, the flagship, is contraindicated in pregnancy, has effects on thyroid hormones that make it a concern in thyroid conditions and with thyroid medication, is generally avoided in autoimmune conditions without oversight, and carries a rare liver signal. Rhodiola and ginseng have their own interaction profiles. None of this makes adaptogens dangerous, but it does retire the idea that a natural stress herb is risk-free by definition.
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
Our position on adaptogens is the same as our position on everything: the word is not the evidence. We would rather point you to one herb that has been studied than to a blend that borrows credibility from a category name.
That is why, of the adaptogens, we offer ashwagandha as a stress tonic and describe it exactly as the trials allow: moderate support for a stressed, cortisol-elevated system, working over roughly two months, not a same-day calm button. If you want the fuller picture, our complete ashwagandha guide walks through the studies and the contraindications, and our piece on which adaptogens have real evidence sorts the shortlist from the marketing.
1. Panossian A, Wikman G (2010). Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals, 3(1):188-224. PMC3991026. Review setting out the adaptogen concept and criteria, building on the earlier Lazarev and Brekhman framework. 2. National Center for Complementary and Integrative Health (2023). Ashwagandha. Government evidence synthesis describing the stress evidence as promising but not settled, with safety cautions. 3. European Medicines Agency, HMPC (2011). Community herbal monograph on Rhodiola rosea L., rhizoma et radix. Traditional-use registration for temporary symptoms of stress-related fatigue and weakness. 4. Chandrasekhar K, et al. (2012). A prospective, randomised, double-blind, placebo-controlled study of ashwagandha root extract in reducing stress and anxiety, 64 adults. Indian Journal of Psychological Medicine. 27.9 per cent reduction in serum cortisol over 60 days.
It is a pharmacological concept describing a plant that helps the body cope with stress by modulating the stress response toward balance, rather than acting as a stimulant or a sedative. The idea is that an adaptogen raises resistance to a wide range of stressors and helps the system return to baseline. It is a functional description of a proposed effect, not a chemical class or an officially defined term, so the quality of evidence varies enormously between herbs sold under the label.
The herbs with the most credible human evidence for stress-related effects are ashwagandha, rhodiola and Asian ginseng. Ashwagandha has the deepest clinical trial base, mostly for chronic stress and cortisol. Rhodiola has moderate evidence for fatigue. Many other plants sold as adaptogens, including a long tail of mushrooms and roots, have little more than traditional use and preclinical data behind the claim.
For a small number of them, in the right population, the evidence is reasonable. Ashwagandha reduces elevated cortisol and self-reported stress in chronically stressed adults over roughly two months. Beyond that shortlist, the honest answer is that the evidence thins quickly, and the word adaptogen on a label tells you nothing about whether that particular product has been tested.
No. No medicines regulator, including the MHRA in the UK, the EMA in Europe or the FDA in the US, formally recognises adaptogen as a category. It is a marketing and research term. A product can call itself adaptogenic without meeting any official standard, which is exactly why you should look at the specific herb and its evidence rather than the label.
A stimulant such as caffeine pushes the nervous system in one direction, upward, whether or not that is useful in the moment. An adaptogen is proposed to do something more regulatory: to blunt an excessive stress response when it is too high and support function when it is depleted, without the crash of a stimulant. That bidirectional, normalising claim is central to the definition, though it is easier to state than to prove.
Innocuousness is one of the original criteria, but it is a claim about the category, not a guarantee for every herb. Ashwagandha has thyroid, autoimmune and pregnancy cautions and a rare liver signal. Rhodiola and ginseng have their own interactions. Safe means low harm at sensible doses in healthy adults, not safe for everyone in every situation.
If they help at all, it is generally over weeks, not hours. The best-studied adaptogenic effect, ashwagandha on cortisol and stress, emerges over roughly 60 days in trials. Anything promising an instant calm-down is describing a sedative effect or a placebo, not the slow, regulatory action the adaptogen concept is built on.
Not on its own. Because the term is unregulated, an adaptogen blend can contain a well-studied herb at a trial-level dose or a pinch of something with no human evidence at all. The useful questions are which specific herbs are in it, at what dose, and whether that herb has been studied at that dose. A named, standardised, adequately dosed single herb tells you more than a proprietary adaptogen blend.
No, the two are separate questions. Lack of a regulatory category reflects how supplements are governed, not whether a given herb has evidence. Ashwagandha has real trial data despite the word adaptogen having no legal standing. The point is that you cannot rely on the label to do the vetting for you, so judge the herb, not the category name.
Ashwagandha is the sensible starting point because it has the deepest human evidence, specifically for chronically stressed adults with elevated cortisol, and it works over about two months rather than overnight. It is not for everyone: pregnancy, thyroid conditions and autoimmune conditions are cautions. Start there, set a two-month expectation, and check with a clinician if you take medication.